Table 4: Factors associated with attitude towards antipsychotic medications during multiple linear regression analysis (n=393).

VariablesCrude unstandardized β coefficient (95% CI)Adjusted unstandardized β coefficient (95% CI)

Residence
Rural00
Urban-0.59 (-1.06, -0.12)-0.10 (-0.29, 0.11)

Age of onset of illness0.03 (0.002, 0.060)0.02 (-0.20, 0.24)

duration of illness
>10 years00
5-10 years0.36 (-0.10, 0.82)-0.08 (-0.31, 0.15)
≤5 years-2.49 (-2.92, -2.05)-0.39 (-0.63, -0.15)

PANSS positive score-0.2 (-0.209, -0.181)-0.07 (-0.09, -0.05)

PANSS negative score-0.19 (-0.21, -0.17)-0.04 (-0.06, -.02)

PANSS general psychopathology score-0.09 (-0.10, -0.08)-0.004 (-0.01, 0.004)

BIS total score0.49 (0.46, 0.52)0.24 (0.20, 0 .27 )

Class of drugs
SGAs00
FGAs+ SGAs-0.58 (-1.19, 0.03)-0.17 (-0.47, 0.13)
FGAs-1.89 (-2.30, -1.48)-0.35 (-0.55, -0.14)

No of Antipsychotics
Single00
≥2-1.64 (-2.16, -1.11)-0.15 (-0.42, 0.12)

Route of use
Oral00
Parenteral-1.36 (-1.83, -0.89)0.02 (-0.21, 0.25)

Sedation side effects
No00
Yes-2.59 (-2.99, -2.20)-0.28 (-0.52,-0.02)

EPS symptoms
No00
Yes-2.59 (-2.96, -2.23)-0.34 (-0.59, -0.01)

Sexual dysfunction
No00
Yes-0.75 (-1.19, -0.31)0.01 (-0.19, 0.20)

Current substance use
No00
Yes-1.54 (-2.00, -1.08)0.02 (-0.20, 0.24)

Note; p<0.05, p< 0.01, p< 0.001
Adjusted R2= 79.9%, F-test p-value<0.001.